BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,196,150 | -91.0% | 3,295,000 | -90.9% | 0.00% | -100.0% |
| Q2 2023 | $35,651,491 | -4.0% | 36,295,000 | +0.3% | 0.00% | 0.0% |
| Q1 2023 | $37,135,346 | -3.7% | 36,195,000 | -0.4% | 0.00% | 0.0% |
| Q4 2022 | $38,567,642 | +161.4% | 36,340,000 | +144.1% | 0.00% | 0.0% |
| Q3 2022 | $14,753,000 | +3.9% | 14,890,000 | +3.8% | 0.00% | – |
| Q2 2022 | $14,202,000 | +9.1% | 14,345,000 | +10.2% | 0.00% | – |
| Q1 2022 | $13,013,000 | +5.3% | 13,020,000 | +10.2% | 0.00% | – |
| Q4 2021 | $12,359,000 | +104.0% | 11,820,000 | +99.7% | 0.00% | – |
| Q3 2021 | $6,057,000 | +5.9% | 5,920,000 | +7.2% | 0.00% | – |
| Q2 2021 | $5,721,000 | +20.4% | 5,520,000 | +17.6% | 0.00% | – |
| Q1 2021 | $4,751,000 | +17.7% | 4,695,000 | +24.9% | 0.00% | – |
| Q4 2020 | $4,035,000 | +55.4% | 3,760,000 | +51.9% | 0.00% | – |
| Q3 2020 | $2,597,000 | -28.6% | 2,475,000 | -16.8% | 0.00% | – |
| Q2 2020 | $3,636,000 | +40.2% | 2,975,000 | +20.2% | 0.00% | – |
| Q1 2020 | $2,594,000 | +139.5% | 2,475,000 | +141.5% | 0.00% | – |
| Q4 2019 | $1,083,000 | +7.4% | 1,025,000 | 0.0% | 0.00% | – |
| Q3 2019 | $1,008,000 | -5.3% | 1,025,000 | 0.0% | 0.00% | – |
| Q2 2019 | $1,064,000 | +1.4% | 1,025,000 | 0.0% | 0.00% | – |
| Q1 2019 | $1,049,000 | -12.1% | 1,025,000 | -14.6% | 0.00% | – |
| Q4 2018 | $1,193,000 | +9.2% | 1,200,000 | +17.1% | 0.00% | – |
| Q3 2018 | $1,092,000 | +54.5% | 1,025,000 | +46.4% | 0.00% | – |
| Q2 2018 | $707,000 | -31.6% | 700,000 | -36.4% | 0.00% | – |
| Q1 2018 | $1,033,000 | -20.2% | 1,100,000 | -15.4% | 0.00% | – |
| Q4 2017 | $1,295,000 | -1.7% | 1,300,000 | 0.0% | 0.00% | – |
| Q3 2017 | $1,317,000 | – | 1,300,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,732,000 | $16,408,385 | 1.23% |
| SONA ASSET MANAGEMENT (US) LLC | 23,125,000 | $22,451,923 | 0.93% |
| SSI INVESTMENT MANAGEMENT LLC | 8,726,000 | $8,464,220 | 0.69% |
| PFM Health Sciences, LP | 15,000,000 | $14,587,500 | 0.69% |
| RWC Asset Management LLP | 10,000,000 | $9,709,000 | 0.63% |
| Sonora Investment Management Group, LLC | 6,245,000 | $6,108,182 | 0.52% |
| Paloma Partners Management Co | 10,006,000 | $9,733,285 | 0.34% |
| MACKAY SHIELDS LLC | 9,891,000 | $9,594,270 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 8,704,000 | $8,455,066 | 0.24% |
| Centiva Capital, LP | 10,000,000 | $9,716,288 | 0.21% |